These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 23995863

  • 21. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
    Ong LM, Hooi LS, Lim TO, Goh BL, Ahmad G, Ghazalli R, Teo SM, Wong HS, Tan SY, Shaariah W, Tan CC, Morad Z.
    Nephrology (Carlton); 2005 Oct; 10(5):504-10. PubMed ID: 16221103
    [Abstract] [Full Text] [Related]

  • 22. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM, Sahin S, Kiziltas S, Masatlioglu S, Oguz F, Ergin H.
    Ren Fail; 2008 Oct; 30(9):865-9. PubMed ID: 18925525
    [Abstract] [Full Text] [Related]

  • 23. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.
    Dall'Era M, Stone D, Levesque V, Cisternas M, Wofsy D.
    Arthritis Care Res (Hoboken); 2011 Mar; 63(3):351-7. PubMed ID: 21080348
    [Abstract] [Full Text] [Related]

  • 24. [Mycophenolate mofetil maintenance therapy in lupus nephritis].
    Milewski M, Jakieła B, Zółciński M, Chmielewska A, Musiał J.
    Pol Arch Med Wewn; 2006 Oct; 116(4):947-54. PubMed ID: 18416296
    [Abstract] [Full Text] [Related]

  • 25. Response to combination of mycophenolate mofetil, cyclosporin A and corticosteroid treatment in lupus nephritis patients with persistent proteinuria.
    Kasitanon N, Boripatkosol P, Louthrenoo W.
    Int J Rheum Dis; 2018 Jan; 21(1):200-207. PubMed ID: 28901731
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of tacrolimus versus mycophenolate mofetil as induction treatment and low-dose tacrolimus as treatment for lupus nephritis: a meta-analysis.
    Lee YH, Song GG.
    Z Rheumatol; 2023 Nov; 82(9):754-762. PubMed ID: 36607421
    [Abstract] [Full Text] [Related]

  • 27. Treatment of lupus nephritis by mycophenolate mofetil.
    Rabrenović V, Poskurica M, Kovacević Z, Nesić V, Savin M, Mitić B, Dimković N, Cucković C, Vujić D, Pljesa S, Perunicić-Peković G, Curić S, Mitić I, Ratković M, Marinković J, Jovanović D.
    Kidney Blood Press Res; 2010 Nov; 33(4):297-303. PubMed ID: 20664209
    [Abstract] [Full Text] [Related]

  • 28. Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy.
    Mao Y, Yin L, Huang H, Zhou Z, Chen T, Zhou W.
    J Int Med Res; 2019 Jan; 47(1):105-113. PubMed ID: 30208769
    [Abstract] [Full Text] [Related]

  • 29. The safety and efficacy of MMF in lupus nephritis: a pilot study.
    Kingdon EJ, McLean AG, Psimenou E, Davenport A, Powis SH, Sweny P, Burns A.
    Lupus; 2001 Jan; 10(9):606-11. PubMed ID: 11678448
    [Abstract] [Full Text] [Related]

  • 30. Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial.
    Sedhain A, Hada R, Agrawal RK, Bhattarai GR, Baral A.
    BMC Nephrol; 2018 Jul 11; 19(1):175. PubMed ID: 29996800
    [Abstract] [Full Text] [Related]

  • 31. Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens.
    Wlodarczyk Z, Walaszewski J, Perner F, Vitko S, Ostrowski M, Bachleda P, Kokot F, Klinger M, Szenohradszky P, Studenik P, Navratil P, Asztalos L, Rutkowski B, Kalmar KN, Hickey D.
    Transpl Int; 2005 Feb 11; 18(2):157-62. PubMed ID: 15691267
    [Abstract] [Full Text] [Related]

  • 32. Lupus nephritis: treatment with mycophenolate mofetil.
    Kapitsinou PP, Boletis JN, Skopouli FN, Boki KA, Moutsopoulos HM.
    Rheumatology (Oxford); 2004 Mar 11; 43(3):377-80. PubMed ID: 14963204
    [Abstract] [Full Text] [Related]

  • 33. Mycophenolate mofetil for remission induction in severe lupus nephritis.
    Cross J, Dwomoa A, Andrews P, Burns A, Gordon C, Main J, Mathieson P, O'Donoghue D, Jayne D, Renal Association Clinical Trials Subcommittee.
    Nephron Clin Pract; 2005 Mar 11; 100(3):c92-100. PubMed ID: 15824513
    [Abstract] [Full Text] [Related]

  • 34. Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study.
    Boletis JN, Marinaki S, Skalioti C, Lionaki SS, Iniotaki A, Sfikakis PP.
    Nephrol Dial Transplant; 2009 Jul 11; 24(7):2157-60. PubMed ID: 19179411
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial.
    Sundel R, Solomons N, Lisk L, Aspreva Lupus Management Study (ALMS) Group.
    Lupus; 2012 Nov 11; 21(13):1433-43. PubMed ID: 22922564
    [Abstract] [Full Text] [Related]

  • 36. Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
    Wang J, Hu W, Xie H, Zhang H, Chen H, Zeng C, Liu Z, Li L.
    Lupus; 2007 Nov 11; 16(9):707-12. PubMed ID: 17728363
    [Abstract] [Full Text] [Related]

  • 37. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study.
    Tanaka H, Oki E, Tsugawa K, Nonaka K, Suzuki K, Ito E.
    Lupus; 2007 Nov 11; 16(11):896-900. PubMed ID: 17971363
    [Abstract] [Full Text] [Related]

  • 38. Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis.
    Jesus D, Rodrigues M, da Silva JAP, Inês L.
    Lupus; 2018 Jul 11; 27(8):1358-1362. PubMed ID: 29448882
    [Abstract] [Full Text] [Related]

  • 39. Mycophenolate mofetil therapy in lupus nephritis: clinical observations.
    Dooley MA, Cosio FG, Nachman PH, Falkenhain ME, Hogan SL, Falk RJ, Hebert LA.
    J Am Soc Nephrol; 1999 Apr 11; 10(4):833-9. PubMed ID: 10203368
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
    Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, Lau CS, Wong AK, Tong MK, Chan KW, Lai KN.
    N Engl J Med; 2000 Oct 19; 343(16):1156-62. PubMed ID: 11036121
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.